Urgent Action Needed: Addressing the Mpox Outbreak and Vaccine Challenges

The global response to the new mpox outbreak, particularly the clade 1b strain, has been slow, with significant challenges in testing and treatment development. Despite some progress, such as accelerated vaccine approvals and regional leadership from Africa CDC, the lack of effective point-of-care tests and treatments hampers containment efforts. The 100 Days Mission framework highlights the need for rapid action, but the world must improve its pandemic preparedness and response to prevent future outbreaks from escalating.